Company / Goodwill
Ultragenyx Pharmaceutical Inc. Goodwill History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$44.0M
FY2025
5-year range
$44.0M / $44.4M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#49 of 74
Health Care
What the data says
At $44M, Ultragenyx Pharmaceutical Inc.'s goodwill ranks #49 of 74 in the Health Care sector. Goodwill remained relatively stable over the past 9 years, with values between $44M and $44M.
Based on SEC 10-K filings.
$44M in FY2025 with a 5-year CAGR of -0.2%.
Remained stable around $44M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- -0.3%
- 5-Year CAGR
- -0.2%
- 10-Year CAGR
- -
Sector benchmark
#49 of 74 in Health CareTop 66% of 74This company $44.0M Sector average $4.0B
▼
-98.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -0.2%, indicating a declining trend.
- In FY2025, goodwill increased 0.0% year-over-year.
- Ranks #49 out of 74 companies in the Health Care sector.
- Peak goodwill was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $44.0M | +0.0% |
| FY2024 | $44.0M | -0.9% |
| FY2023 | $44.4M | +0.0% |
| FY2022 | $44.4M | +0.0% |
| FY2021 | $44.4M | +0.0% |
| FY2020 | $44.4M | +0.0% |
| FY2019 | $44.4M | +0.0% |
| FY2018 | $44.4M | +0.0% |
| FY2017 | $44.4M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026